Five Star Equities Provides Stock Research on Aegerion Pharmaceuticals and Alnylam
Continue ReadingCategory: Investment Services & Trading
FDA-s New “Breakthrough” Designation Allows New Drugs to Gain Approval After Just 1 Round of Testing
Five Star Equities Provides Stock Research on Idenix Pharmaceuticals and Peregrine Pharmaceuticals
Continue Reading
New Programs Designed to Speed Up Approval Process a Key Factor in Biotech Industry-s Growth in 2012
Five Star Equities Provides Stock Research on Halozyme Therapeutics and Novavax
Continue Reading
GRNE Reports Revenue of $262,140 for February 2013; Up 19.1% Over February 2012
SALT LAKE CITY, UT -- (Marketwire) -- 03/11/13 -- (PINKSHEETS: GRNE), a majority owned subsidiary of…
Continue Reading
CITIC Securities Selects Advent to Support Growth Strategy
Leading Chinese Investment Bank Chooses Advent-s Geneva(R) Solution for Hedge Fund Business
Continue ReadingNorthfield Capital Corporation Acquires Securities of Nighthawk Gold Corp.
TORONTO, ONTARIO -- (Marketwire) -- 03/08/13 -- Northfield Capital Corporation ("Northfield") (TSX VENTURE: NFDA) of 141…
Continue Reading
Crossroads Systems Announces Workforce Reduction
AUSTIN, TX -- (Marketwire) -- 03/08/13 -- Crossroads Systems, Inc. (NASDAQ: CRDS), a global provider of…
Continue Reading
New Partnership Brings Growth Opportunities for Startups
TORONTO, ONTARIO -- (Marketwire) -- 03/08/13 -- The Canadian National Stock Exchange (CNSX) announced today a…
Continue Reading
Triax Diversified High-Yield Trust Announces Normal Course Issuer Bid For Units
TORONTO, ONTARIO -- (Marketwire) -- 03/08/13 -- Triax Diversified High-Yield Trust (the "Fund") (TSX: TRH.UN) announced…
Continue Reading